Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 456.13 | N/A |
| PEG Ratio (TTM) | 5.24 | N/A |
| P/S Ratio (TTM) | 1.12 | N/A |
| P/B Ratio (TTM) | 0.59 | N/A |
| P/FCF Ratio (TTM) | 16.86 | N/A |
| Price to 5YR AVG Earnings Ratio | -14.04 | N/A |
| Price to 5YR AVG FCF Ratio | 17.95 | N/A |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.06% | N/A |
| ROE (TTM) | 0.13% | N/A |
| Net Profit Margin (TTM) | 0.25% | N/A |
| ROIC 5YR AVG | -0.23% | N/A |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 79.37% | -91.65% | -52.76% |
| Revenue | 1.68% | 29.18% | 35.89% |
| Net Income | 80.28% | 124.80% | 87.40% |
| Cash Flow | 12.45% | 58.42% | 90.78% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.55 | N/A |
| Quick Ratio (TTM) | 0.55 | N/A |
| D/E Ratio (TTM) | 0.79 | N/A |
| Interest Coverage (TTM) | 1.51 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.25 | N/A |
| LTL to 5YR AVG FCF | 24.05 | N/A |
| Shares Outstanding Growth 5YR AVG | 14.22% | N/A |